Order Article Reprints

Sulaiman R, De P, Aske JC, Lin X, Dale A, Koirala N, Gaster K, Espaillat LR, Starks D, Dey N. Patient-Derived Primary Cancer-Associated Fibroblasts Mediate Resistance to Anti-Angiogenic Drug in Ovarian Cancers. Biomedicines. 2023; 11(1):112. https://doi.org/10.3390/biomedicines11010112

Sulaiman, Raed, Pradip De, Jennifer C. Aske, Xiaoqian Lin, Adam Dale, Nischal Koirala, Kris Gaster, Luis Rojas Espaillat, David Starks, and Nandini Dey. 2023. "Patient-Derived Primary Cancer-Associated Fibroblasts Mediate Resistance to Anti-Angiogenic Drug in Ovarian Cancers" Biomedicines 11, no. 1: 112. https://doi.org/10.3390/biomedicines11010112

Sulaiman, R., De, P., Aske, J. C., Lin, X., Dale, A., Koirala, N., Gaster, K., Espaillat, L. R., Starks, D., & Dey, N. (2023). Patient-Derived Primary Cancer-Associated Fibroblasts Mediate Resistance to Anti-Angiogenic Drug in Ovarian Cancers. Biomedicines, 11(1), 112. https://doi.org/10.3390/biomedicines11010112